Patient with long-term response treated with axitinib
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.date.accessioned | 2020-06-08T09:46:01Z | |
dc.date.available | 02-31-2020 | en |
dc.date.available | 2020-06-08T09:46:01Z | |
dc.date.issued | 2020-01-01 | cs |
dc.date.updated | 05-59-2020 | en |
dc.format.extent | 4 | cs |
dc.identifier.issn | 1805-398X | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/156244 | |
dc.language.iso | cze | cs |
dc.publisher | Faculty of Medicine | cs |
dc.publisher.city | Hradec Králové | cs |
dc.relation.ispartof | Acta medicinae | en |
dc.relation.ispartofseries | 0 | cs |
dc.subject | metastatic renal cell carcinoma | cs |
dc.subject | targeted treatment | cs |
dc.subject | immunotherapy | cs |
dc.subject | long-term response rate | cs |
dc.subject | axitinib | cs |
dc.title | Patient with long-term response treated with axitinib | en |
dc.title | Kazuistika s dlouhodobou léčebnou odpovědí na terapii axitinibem | cs |
local.citation.epage | 15-18 | cs |
local.citation.spage | 15-18 | cs |
local.identifier.publikace | 6952 | |
local.relation.issue | 4 | cs |